Johnpro Biotech, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM (NCT03008148) | Johnpro Biotech, Inc. | 2018-10-11 |
Track Johnpro Biotech, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.